Through market and patient research, the key enablers for these outcomes include transitioning from intravenous to subcutaneous injections, combination therapies, as well as new device technologies. Together these enablers are leading to new possibilities and improving patient outcomes.

This webinar will explore:

• Why adherence, safety and quality of life are important for patients
• How these key enablers contribute towards positive outcomes
• Existing challenges, such as drug development, regulatory, patient accessibility
• How device technologies can further improve patient outcomes